Über die Firma
Patients with a rheumatic disease should be able to lead a completely normal life without restrictions. This is why we – at Midaia – have set ourselves the goal of improving the health and well-being of all patients with rheumatic diseases.
Midaia will revolutionize the treatment of rheumatic diseases. We use artificial intelligence to predict the best individual treatment. This allows patients to choose the therapy with the highest efficacy and safety. With personalized medicine, we support patients in dealing with the best therapy in order to enable each patient to lead a completely normal life in the long term.
Midaia is backed by an international team of doctors, health experts and IT specialists.